(0.04%) 5 250.53 points
(0.00%) 39 761 points
(-0.17%) 16 372 points
(1.75%) $82.77
(1.63%) $1.746
(1.24%) $2 240.20
(0.66%) $24.92
(1.15%) $920.15
(0.29%) $0.926
(0.76%) $10.85
(0.09%) $0.792
(0.15%) $92.58
Live Chart Being Loaded With Signals
Tibet AIM Pharm. Inc. engages in the research and development of medical products in China. The company's products include Miglitol tablets for diabetes; Gualoupi injection for coronary disease; Oxytocin injection for gynecology and obstetrics; NalMefene injection for various acute poisoning, such as alcohol, organic phosphor, CO, sedative-hypnotic, opioid substance, serious infection, shock, fainting, and brain; Carbetocin injections; and Hongjin Xiaojie tablets and Aceclofenac Enteric-Coated tablets, as well as for the treatment of antibiotic, antiallergic, and digestive system...
Stats | |
---|---|
Today's Volume | 5.25M |
Average Volume | 6.24M |
Market Cap | 1.60B |
EPS | CNY0.0273 ( 2023-06-30 ) |
Last Dividend | CNY0 ( N/A ) |
Next Dividend | CNY0 ( N/A ) |
P/E | 33.56 |
ATR14 | CNY0.0190 (0.23%) |
Volume Correlation
Tibet AIM Pharm. Inc. Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Tibet AIM Pharm. Inc. Correlation - Currency/Commodity
Tibet AIM Pharm. Inc. Financials
Annual | 2022 |
Revenue: | CNY856.73M |
Gross Profit: | CNY376.17M (43.91 %) |
EPS: | CNY0.230 |
Q3 | 2023 |
Revenue: | CNY161.87M |
Gross Profit: | CNY93.11M (57.52 %) |
EPS: | CNY0.0514 |
Q2 | 2023 |
Revenue: | CNY205.00M |
Gross Profit: | CNY93.74M (45.73 %) |
EPS: | CNY0.0296 |
Q1 | 2023 |
Revenue: | CNY171.43M |
Gross Profit: | CNY75.96M (44.31 %) |
EPS: | CNY0.0400 |
Financial Reports:
No articles found.
Tibet AIM Pharm. Inc.
Tibet AIM Pharm. Inc. engages in the research and development of medical products in China. The company's products include Miglitol tablets for diabetes; Gualoupi injection for coronary disease; Oxytocin injection for gynecology and obstetrics; NalMefene injection for various acute poisoning, such as alcohol, organic phosphor, CO, sedative-hypnotic, opioid substance, serious infection, shock, fainting, and brain; Carbetocin injections; and Hongjin Xiaojie tablets and Aceclofenac Enteric-Coated tablets, as well as for the treatment of antibiotic, antiallergic, and digestive system. Tibet AIM Pharm. Inc. was founded in 2003 and is headquartered in Beijing, China.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators